tiprankstipranks
Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO
Holding SPRO?
Track your performance easily

Spero Therapeutics (SPRO) Financial Statements

508 Followers

Spero Therapeutics Financial Overview

Spero Therapeutics's market cap is currently ―. The company's EPS TTM is $0.079; its P/E ratio is 14.36; Spero Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 13.47M$ 10.20M$ 9.27M$ 70.50M$ 23.38M
Gross Profit$ 13.47M$ 10.20M$ 9.27M$ 75.45M$ 25.47M
EBIT$ -17.39M$ -17.86M$ -21.80M$ 51.58M$ -994.00K
EBITDA$ -17.39M$ -17.86M$ -21.80M$ 51.62M$ -886.00K
Net Income Common Stockholders$ -17.10M$ -17.86M$ -12.67M$ 51.19M$ -3.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 76.29M$ 63.53M$ 82.27M$ 76.33M$ 93.83M
Total Assets$ 135.16M$ 149.88M$ 167.70M$ 182.39M$ 107.10M
Total Debt$ 4.63M$ 4.96M$ 5.28M$ 5.63M$ 5.89M
Net Debt$ -71.66M$ -58.56M$ -76.99M$ -70.70M$ -87.93M
Total Liabilities$ 69.65M$ 69.38M$ 71.45M$ 75.50M$ 53.40M
Stockholders Equity$ 65.51M$ 80.50M$ 96.25M$ 106.89M$ 53.70M
Cash Flow-
Free Cash Flow$ 12.76M$ -18.74M$ 5.94M$ -17.49M$ 15.91M
Operating Cash Flow$ 12.76M$ -18.74M$ 5.94M$ -17.49M$ 15.91M
Investing Cash Flow-----
Financing Cash Flow---$ 1.00K$ 220.00K
Currency in USD

Spero Therapeutics Earnings and Revenue History

Spero Therapeutics Debt to Assets

Spero Therapeutics Cash Flow

Spero Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis